12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Other News

Bavarian Nordic, U.S. Department of Health and Human Services infectious news

HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Bavarian Nordic a contract valued at up to $228 million to supply 8 million doses of frozen Imvamune smallpox vaccine to the U.S. Strategic National Stockpile. The company said the first $110 million is secured and the remaining portion will be secured based on available funds in 2014. Bavarian Nordic has...

Read the full 287 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >